Cytek Biosciences Q1 EPS $(0.09) Misses $(0.04) Estimate, Sales $51.93M Beat $42.66M Estimate

Benzinga · 05/08 20:26
Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.04) by 125 percent. This is a 80 percent decrease over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $51.93 million which beat the analyst consensus estimate of $42.66 million by 21.72 percent. This is a 15.76 percent increase over sales of $44.86 million the same period last year.